ABO Blood Groups and Cardiovascular Diseases

ABO blood groups have been associated with various disease phenotypes, particularly cardiovascular diseases. Cardiovascular diseases are the most common causes of death in developed countries and their prevalence rate is rapidly growing in developing countries. There have been substantial historical...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanrui Zhang, Ciarán J. Mooney, Muredach P. Reilly
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Vascular Medicine
Online Access:http://dx.doi.org/10.1155/2012/641917
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565849480757248
author Hanrui Zhang
Ciarán J. Mooney
Muredach P. Reilly
author_facet Hanrui Zhang
Ciarán J. Mooney
Muredach P. Reilly
author_sort Hanrui Zhang
collection DOAJ
description ABO blood groups have been associated with various disease phenotypes, particularly cardiovascular diseases. Cardiovascular diseases are the most common causes of death in developed countries and their prevalence rate is rapidly growing in developing countries. There have been substantial historical associations between non-O blood group status and an increase in some cardiovascular disorders. Recent GWASs have identified ABO as a locus for thrombosis, myocardial infarction, and multiple cardiovascular risk biomarkers, refocusing attention on mechanisms and potential for clinical advances. As we highlight in this paper, more recent work is beginning to probe the molecular basis of the disease associations observed in these observational studies. Advances in our understanding of the physiologic importance of various endothelial and platelet-derived circulating glycoproteins are elucidating the mechanisms through which the ABO blood group may determine overall cardiovascular disease risk. The role of blood group antigens in the pathogenesis of various cardiovascular disorders remains a fascinating subject with potential to lead to novel therapeutics and prognostics and to reduce the global burden of cardiovascular diseases.
format Article
id doaj-art-3d7cea1502b3479e8858d16ae523c314
institution Kabale University
issn 2090-2824
2090-2832
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Vascular Medicine
spelling doaj-art-3d7cea1502b3479e8858d16ae523c3142025-02-03T01:06:20ZengWileyInternational Journal of Vascular Medicine2090-28242090-28322012-01-01201210.1155/2012/641917641917ABO Blood Groups and Cardiovascular DiseasesHanrui Zhang0Ciarán J. Mooney1Muredach P. Reilly2Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USACardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USACardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6160, USAABO blood groups have been associated with various disease phenotypes, particularly cardiovascular diseases. Cardiovascular diseases are the most common causes of death in developed countries and their prevalence rate is rapidly growing in developing countries. There have been substantial historical associations between non-O blood group status and an increase in some cardiovascular disorders. Recent GWASs have identified ABO as a locus for thrombosis, myocardial infarction, and multiple cardiovascular risk biomarkers, refocusing attention on mechanisms and potential for clinical advances. As we highlight in this paper, more recent work is beginning to probe the molecular basis of the disease associations observed in these observational studies. Advances in our understanding of the physiologic importance of various endothelial and platelet-derived circulating glycoproteins are elucidating the mechanisms through which the ABO blood group may determine overall cardiovascular disease risk. The role of blood group antigens in the pathogenesis of various cardiovascular disorders remains a fascinating subject with potential to lead to novel therapeutics and prognostics and to reduce the global burden of cardiovascular diseases.http://dx.doi.org/10.1155/2012/641917
spellingShingle Hanrui Zhang
Ciarán J. Mooney
Muredach P. Reilly
ABO Blood Groups and Cardiovascular Diseases
International Journal of Vascular Medicine
title ABO Blood Groups and Cardiovascular Diseases
title_full ABO Blood Groups and Cardiovascular Diseases
title_fullStr ABO Blood Groups and Cardiovascular Diseases
title_full_unstemmed ABO Blood Groups and Cardiovascular Diseases
title_short ABO Blood Groups and Cardiovascular Diseases
title_sort abo blood groups and cardiovascular diseases
url http://dx.doi.org/10.1155/2012/641917
work_keys_str_mv AT hanruizhang abobloodgroupsandcardiovasculardiseases
AT ciaranjmooney abobloodgroupsandcardiovasculardiseases
AT muredachpreilly abobloodgroupsandcardiovasculardiseases